Research location
Los Gatos
California, United States
Advertisement
Research activity in Los Gatos
California, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 88 trials and 88 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Los Gatos
88 linked trials · page 1 of 2Opicapone Treatment Initiation Open-Label StudyNCT04787965 · 2021-03-01 · 1 site observation
COMPLETED
Trial of Parkinson's And Zoledronic AcidNCT03924414 · 2019-11-15 · 1 site observation
COMPLETED
Mylan Insulin Aspart StudyNCT03760068 · 2018-11-07 · 1 site observation
COMPLETED
Obalon Balloon System Post-Approval StudyNCT03570034 · 2018-06-15 · 1 site observation
UNKNOWN
Effect of Efpeglenatide on Cardiovascular OutcomesNCT03496298 · 2018-04-27 · 1 site observation
TERMINATED
Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic AgentsNCT03434119 · 2018-02-20 · 1 site observation
TERMINATED
Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular RiskNCT03315143 · 2017-12-19 · 1 site observation
TERMINATED
Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)NCT03944785 · 2017-11-30 · 1 site observation
COMPLETED
Mylan Insulin Glargine StudyNCT03376789 · 2017-11-29 · 1 site observation
COMPLETED
This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)NCT03165227 · 2017-10-17 · 1 site observation
COMPLETED
The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) StudyNCT03152292 · 2017-03-30 · 1 site observation
TERMINATED
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)NCT03071692 · 2017-03-23 · 1 site observation
TERMINATED
A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes MellitusNCT02688933 · 2016-05-05 · 1 site observation
COMPLETED
Phase 3 Gene Therapy for Painful Diabetic NeuropathyNCT02427464 · 2016-04-01 · 1 site observation
COMPLETED
A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKDNCT02547935 · 2015-09-21 · 1 site observation
COMPLETED
18F-AV-1451 Autopsy StudyNCT02516046 · 2015-09-01 · 1 site observation
COMPLETED
TME Neoadjuvant Breast RegistryNCT02596724 · 2015-07-01 · 1 site observation
UNKNOWN
A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)NCT02451137 · 2015-06-16 · 1 site observation
COMPLETED
A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 DiabetesNCT02413398 · 2015-06-15 · 1 site observation
COMPLETED
Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)NCT02227875 · 2014-08-01 · 1 site observation
COMPLETED
Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)NCT02227862 · 2014-06-01 · 1 site observation
COMPLETED
A Study of Effects of Canagliflozin as Add-on Therapy to Insulin in the Treatment of Participants With Type 1 Diabetes Mellitus (T1DM)NCT02139943 · 2014-05-01 · 1 site observation
COMPLETED
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)NCT01897532 · 2013-07-10 · 1 site observation
COMPLETED
Diabetes Assistant (DiAs) Control-to-Range (CTR) Nocturnal Closed-Loop Camp StudyNCT01973413 · 2013-07-01 · 1 site observation
COMPLETED
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic NephropathyNCT01874431 · 2013-06-12 · 1 site observation
COMPLETED
A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose AbnormalitiesNCT01715818 · 2012-12-01 · 1 site observation
COMPLETED
A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt NephropathyNCT01712061 · 2012-12-01 · 1 site observation
COMPLETED
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)NCT01686620 · 2012-08-01 · 1 site observation
COMPLETED
Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes MellitusNCT01451398 · 2011-11-01 · 1 site observation
COMPLETED
Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment PeriodNCT01445951 · 2011-09-01 · 1 site observation
COMPLETED
Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) InhibitorNCT01356849 · 2011-04-01 · 1 site observation
COMPLETED
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesNCT01243424 · 2010-11-11 · 1 site observation
COMPLETED
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).NCT01131676 · 2010-07-01 · 1 site observation
COMPLETED
A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.NCT01098539 · 2010-05-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes AdultsNCT01103284 · 2010-04-01 · 1 site observation
COMPLETED
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral NeuropathyNCT01057693 · 2010-03-31 · 1 site observation
COMPLETED
Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin MonotherapyNCT01066715 · 2010-01-01 · 1 site observation
COMPLETED
CANVAS - CANagliflozin cardioVascular Assessment StudyNCT01032629 · 2009-12-09 · 1 site observation
COMPLETED
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes MellitusNCT01007097 · 2009-12-01 · 1 site observation
COMPLETED
Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 DiabetesNCT01011868 · 2009-11-01 · 1 site observation
COMPLETED
Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 DiabetesNCT00982228 · 2009-09-01 · 1 site observation
COMPLETED
Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 DiabetesNCT00972283 · 2009-09-01 · 1 site observation
COMPLETED
Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary SyndromeNCT00968708 · 2009-09-01 · 1 site observation
COMPLETED
Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes MellitusNCT00789750 · 2009-04-01 · 1 site observation
COMPLETED
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic PatientsNCT00900146 · 2009-04-01 · 1 site observation
TERMINATED
The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 DiabetesNCT00856986 · 2009-03-01 · 1 site observation
COMPLETED
Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care SettingNCT01013948 · 2009-02-01 · 1 site observation
COMPLETED
Welchol as Monotherapy for Type 2 Diabetes MellitusNCT00789737 · 2009-01-01 · 1 site observation
COMPLETED
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.NCT00755287 · 2008-11-01 · 1 site observation
COMPLETED
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 DiabetesNCT00736879 · 2008-09-22 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.